The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

MEDNAX Inc

NYSE: MD
Last

(U.S.) $79.34

Today's change+0.21 +0.27%
Updated September 3 4:05 PM EDT. Delayed by at least 15 minutes.
 

MEDNAX Inc

NYSE: MD
Last

(U.S.) $79.34

Today's change+0.21 +0.27%
Updated September 3 4:05 PM EDT. Delayed by at least 15 minutes.

MEDNAX Inc up (U.S.)$0.21

MEDNAX Inc closed up Thursday by (U.S.)$0.21 or 0.27% to (U.S.)$79.34. Shares have lost 2.71% over the last five days, but have gained 20.01% over the last year to date. This security has outperformed the S&P 500 by 41.06% during the last year.

Key company metrics

  • Open(U.S.) $79.48
  • Previous close(U.S.) $79.13
  • High(U.S.) $80.52
  • Low(U.S.) $79.26
  • Bid / Ask-- / --
  • YTD % change+20.01%
  • Volume742,841
  • Average volume (10-day)850,995
  • Average volume (1-month)658,108
  • Average volume (3-month)681,100
  • 52-week range(U.S.) $49.82 to (U.S.) $86.09
  • Beta0.89
  • Trailing P/E23.52×
  • P/E 1 year forward21.69×
  • Forward PEG1.45×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $3.37
Updated September 3 4:05 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+12.62%

Based on its net profit margin of 12.62%, MEDNAX Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.38%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue677639651627
Total other revenue--------
Total revenue677639651627
Gross profit229196223210
Total cost of revenue448443428416
Total operating expense536525509488
Selling / general / administrative72686861
Research & development--------
Depreciation / amortization16141411
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total----0--
Operating income141115141138
Interest income (expense), net non-operating-5-3-3-2
Gain (loss) on sale of assets--------
Other--------
Income before tax137113139137
Income after tax84698886
Income tax, total53445151
Net income84698886
Total adjustments to net income----0--
Net income before extra. items84698886
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items84698886
Inc. avail. to common incl. extra. items84698886
Diluted net income84698886
Dilution adjustment--------
Diluted weighted average shares939599100
Diluted EPS excluding extraordinary itemsvalue per share0.900.720.890.86
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share0.900.720.890.86